期刊文献+

宫颈癌病理因素与淋巴结转移的关系 被引量:3

Cervical Cancer Pathological Factors and the Relationship between Lymph Node Metastasis
暂未订购
导出
摘要 目的 探讨宫颈癌患者的临床病理特点以及与盆腔淋巴结转移之间的关系,找出淋巴结转移的高危因素。方法 通过回顾性分析我院2010年1月-2013年1月156例宫颈癌患者的临床病理资料,分析其与盆腔淋巴结转移之间的关系。结果 156例患者中有41例发生盆腔淋巴结转移,发生率为26.28%。结论 宫颈癌患者的病理分级、临床分期、浸润深度及肿瘤直径都是影响盆腔淋巴结转移的高危因素,在对宫颈癌患者进行根治手术时应重视这些高危因素的影响。 Objective To study the clinical pathological characteristics of patients with cervix cancer, as well as the relationship between the pelvic lymph node metastasis, find out the risk factors of lymph node metastasis. Methods Through a retrospective analysis of our hospital from January 2010 to January 2010, 156 cases of cervical cancer patients with the clinical pathological data, the relationship between the analysis with the pelvic lymph node metastasis. Results 156 patients occurred in 41 cases of pelvic lymph node metastasis, the incidence was 26.28%. Conclusion Cervical cancer patients with pathological grade, clinical stage and tumor diameter, infiltrating depth are affect the risk factors of pelvic lymph node metastasis, during the radical surgery for cervical cancer patients should pay attention to the impact of these risk factors.
作者 刘晓江
机构地区 临沂市肿瘤医院
出处 《中国卫生标准管理》 2014年第13期6-8,共3页 China Health Standard Management
关键词 宫颈癌 病理因素 淋巴结转移 Cervical cancer Pathological factors Lymph node metastasis
  • 相关文献

参考文献3

二级参考文献22

  • 1Ho CM, Chien TY, Huang SH, et al. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients un- dergoing radical hysterectomy[J]. Gynecol Oncol, 2004, 93(2): 458-464.
  • 2Aoki Y, Sasaki M, Watanabe M, et al. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation[J]. Gynecol Oncol, 2000, 77(2): 305-309.
  • 3Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, HA, and lib cervical carcinoma treated with radical hysterectomy[J]. Cancer, 1999, 85(7): 1547-1554.
  • 4Peters WR, Liu PY, Barrett RN, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix[J].J Clin Oncol, 2000, 18(8): 1606-1613.
  • 5Monk BJ, Wang j, Im s, et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Ra- diation Therapy Oncology Group trial[J].Gynecol Oncol, 2005, 96(3): 721-728.
  • 6Chemofsky MR, Felix JG, Muderspach LI, et al. Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix[J]. Gynecol Oncol, 2006, 100(2): 288-293.
  • 7Marchiole P, Buenerd A, Benchaib M, et al. Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case--control surgico-pathological study[J]. Gynecol Oncol, 2005, 97(3): 727-732.
  • 8Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hys- terectomy for bulky stage IB cervical carcinoma[J].N Engl J Med,1999, 340(15):1154-1161.
  • 9Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent che- motherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer[J].N Engl J Med, 1999, 340(15): 1137-1143.
  • 10Gaarenstroom KN, BonfrerJM, Kenter GG, et al. Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer[J]. Cancer, 1995, 76(5): 807-813.

共引文献55

同被引文献5

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部